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REGULATED APOPTOSIS IN CAENORHABDITIS ELEGANS DEVELOPMENT. 
Nathan Lifton, Alison Kochersberger, and Marc Hammarlund, Department of Genetics, Yale 
University School of Medicine, New Haven, CT. 
We have used chromosome engineering in C. elegans to develop a model animal in which cells 
normally undergoing developmental programmed cell death (DPCD) survive and are visibly 
marked. This system uses three elements: The first is a mutation in the apoptosis activator, ced-
3, that drives developmental programmed cell death, such that cells normally killed by DPCD 
survive. The second is a cassette in which the gene encoding the bacterial enzyme Cre 
recombinase is expressed under transcriptional control of the regulatory elements of the egl-1 
gene (Cre protein induces homologous recombination between specific DNA sequence elements 
called LoxP elements). The third element is a green fluorescent protein (GFP) reporter gene that 
is connected to a constitutively active promoter; however, GFP cannot be produced from this 
construct without the expression of Cre because two exons of GFP are inverted within the gene 
and flanked by inverted LoxP sites. When Cre recombinase is expressed, it will induce flipping of 
exons 2 and 3 of GFP, resulting in an intact GFP that is constitutively expressed, providing a 
permanent mark for cells in which expression at the egl-1 locus was activated even transiently.  
We succeeded in producing worms with the desired constructs by injecting gonads with 
linear extrachromosomal arrays that were integrated at random sites in the genome by induction 
of double strand DNA breaks with trimethylpsoralen and ultraviolet light. 
We developed multiple strains with independent insertions of the egl-1/Cre (4 
independent insertions) and Cre-dependent GFP (3 independent insertions) cassettes, 
demonstrated that each had integrated into a single C. elegans chromosome, and performed 
crosses to produce worms that were homozygous at all three loci (ced-3, egl-1/Cre and Cre-
dependent GFP).  
Preliminary analysis of the resulting worms from two of these strains provides evidence of 
Cre-dependent GFP expression, with reproducible expression of GFP in cells of the posterior 
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Introduction & Statement of Purpose  
Developmental programmed cell death.    
Developmental programmed cell death (DPCD), in which normal, healthy cells 
undergo apoptosis, is an extremely important process that occurs during the 
development of multicellular organisms. DPCD is essential for morphogenesis, 
sexual differentiation, and development of the immune and nervous systems1-7.  
 DPCD can be divided into three phases: specification, killing, and 
execution. In the specification phase, individual cells receive signals that they are 
selected for death. In the killing phase, the apoptotic pathway is activated in 
these individual cells, the end point of which is initiation of the execution phase. 
In the execution phase, enzymes are induced that produce fragmentation and 
degradation of nuclear DNA8-14.  
The cellular mechanisms that mediate the killing and execution phases 
are relatively well understood from elegant genetic studies in C. elegans. The 
killing phase is mediated by a pathway involving the genes egl-1, ced-9, ced-4, 
and ced-3. ced-3 is a pro-apoptotic gene. The enzymatic activity of its encoded 
protein, a cysteine-aspartic acid protease (caspase), is sufficient for inducing the 
downstream execution phase, but needs to be activated by ced-4. ced-4, in turn 
is normally inhibited by ced-9, which in turn is inhibited by egl-1. Thus, in the 
absence of egl-1, the pathway is silent. But upon expression of egl-1, ced-9 can 
no longer inhibit ced-4, which then activates ced-3, thereby activating the cell 
death pathway (Figure 1) 3,15,16. Expression of egl-1 is normally the rate-limiting 
step in this process.  
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Downstream of ced-3 are many genes whose functions perform the 
execution phase of cell death, including digestion of nuclear DNA and induction 
of phagocytosis by surrounding cells. Genes whose encoded proteins are 
involved in genome degradation include nuc-1, cps-6, wah-1, crn-1, 2, 3, 4, 5 and 
617-20. Genes in the surrounding cells have been identified that are required for 
them to phagocytose the dying cells. These include ced-1, ced-2, ced-5, ced-6, 
ced-7, ced-10, ced-12, and psr-121-26. ced-7 is translocated to the cell surface of 
the dying cell, promoting the cell’s phagocytosis by surrounding cells. 
The basic pathway of the killing phase has proved to be highly conserved 
across metazoans, which has contributed to biochemical understanding of the 
function of each gene’s encoded protein27. CED-3 in worms is homologous to 
mammalian caspases, proteases that are the executioners of cell death. CED-3 
is at the top of a proteolytic cascade, activating downstream targets that 
ultimately activate single and double-stranded endonucleases and exonucleases, 
mediating nuclear genome degradation, as well as translocation of CED-7 to the 
cell surface. CED-4 is related to mammalian APAFs, which are proteins that are 
required for binding and activation of CED-3’s caspase activity. ced-9 encodes a 
protein homologous to BCL-2 proteins, which inhibit APAFs by directly binding to 
them and preventing their activation of CED-3-like caspases. egl-1 is 
homologous to BH3 genes, which bind to and inhibit activity of BCL-2 proteins.  
 Similarly, many of the gene products involved in the engulfing cells’ 
phagocytic activity have conserved functions across species. ced-2, ced-5, ced-
10, and ced-12 encode conserved components of the Rac GTPase signaling 
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pathway involved in regulating actin cytoskeleton rearrangement essential for cell 
migration and corpse engulfment. CED-2 is a CrkII-like adaptor with one SH2 
and two SH3 (SRC Homology) domains28. CED-5 is an analogue of the human 
DOCK180, which physically interacts with human CrkII.29 CED-10 is a C. 
elegans homologue of mammalian Rac GTPase, which controls cytoskeletal 
dynamics and cell shape changes28.  Ced-12 contains a potential PH (pleckstrin-
homology) domain and an SH3-binding motif23,25,26. 
Because programmed cell death kills normal cells, its regulation must be 
exquisitely precise. Tracing the lineage of every cell in C. elegans development 
demonstrates that the development of hermaphrodites is invariant, and that, of 
the 1090 cells generated during development of the soma, 131 specific cells 
always die via DPCD at specific stages—113 of these cells die during embryonic 
and 18 during post-embryonic development30. Nonetheless, our understanding of 
the specification phase—the process by which these 131 individual cells are 
invariably selected to die—is incomplete.  
In mammals, two alternative pathways can activate apoptosis. One is cell-
autonomous (intrinsic), while the other is non-cell-autonomous (extrinsic). The 
intrinsic pathway is activated by loss of integrity of the mitochondrial membrane, 
releasing cytochrome C, which activates APAFs (homologs of CED-4). In C. 
elegans, it appears that cell death occurs by a pathway analogous to the intrinsic 
pathway. CED-9 holds CED-4 in an inactive form on the mitochondrial 
membrane, and EGL-1 binding to CED-9 releases CED-4, which can then 
activate CED-3.   
4 
 
The current model for cell death specification in C. elegans is that in the 
959 cells destined to survive, egl-1 expression is low or absent and that in the 
131 cells destined to die, egl-1 expression is at least transiently high, sufficient to 
induce the cell death pathway31. Thus, expression of egl-1 is believed to be the 
rate-limiting step in initiation of DPCD.  
Little is known about the regulators of egl-1 expression. Cis-acting 
regulatory elements have been identified over a large region surrounding egl-1, 
both upstream and downstream of the gene, but only a handful of specific 
transcriptional regulators of egl-1 have been identified. The first of these, the 
transcriptional inhibitor TRA-1, was discovered because of a mutation in the 3’ 
regulatory region of egl-1 that caused ectopic expression of egl-1 due to loss of 
the TRA-1 binding site. 
egl-1 was discovered by a gain of function mutation that causes egl-1 to 
be expressed abnormally in neurons required for egg laying, producing an egg-
laying defective (Egl) phenotype15,32. This mutation results in defective egg laying 
due to death of neurons required for this activity. Screens for suppressors of the 
egg laying defect identified a loss of function allele in egl-1 that prevented DPCD 
of virtually all of the 131 normally affected cells15,33.  Besides tra-1, transcription 
regulators that regulate egl-1 have been identified for only 8 of the 131 cells that 
normally undergo DPCD9,32,34,35. For example, mutation of the gene mab-5, a 
homeobox–containing transcription factor, whose family members play key roles 
in specifying the body plan and developmental cells’ fates in all metazoans, 
results in loss of programmed cell death of two cells that normally die in 
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development. This effect is attributable to loss of the direct transcriptional 
activation of egl-1 by binding of MAB-5 in complex with CEH-20 at the egl-1 
locus35.  Thus, the key regulators of egl-1 expression in the remaining 123 cells 
are unknown and, to date, there have been no unbiased systematic genetic 
screens to identify genes that regulate induction of egl-1. 
A major barrier to investigating the specification of DPCD is the difficulty of 
visualizing DPCD at the cellular level. If DPCD occurs normally, the dead cell is 
removed and cannot be studied. If DPCD is blocked, for example by partial or 
complete loss of function (lf) mutations in egl-1 or ced-3, the cells normally 
undergoing DPCD survive as “undead” cells. However, these undead cells do not 
have a distinctive morphology and cannot be distinguished from normal cells. If 
we could reliably mark these cells, we would have a powerful tool that would 
enable us to do a wide variety of experiments.  
For example, it is presently unknown whether egl-1 is the initiating signal 
for all cells that undergo DPCD. Using a reporter that marks cells in which egl-1 
is expressed with GFP, we could image developing embryos and compare those 
cells marked by GFP to the cell lineages known to undergo DPCD, answering the 
question of whether egl-1 is expressed in all cells undergoing DPCD, or whether 
some cells undergo DPCD independent of egl-1 expression. Similarly, for the 
mutations that have been described to impair DPCD in a handful of cells, it is 
unknown whether these mutations might have broader effects in regulating 
DPCD. This assay would allow reproducible assessment of the spectrum of cells 
that are affected by each mutation.  
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Further, by marking and tracking undead cells, we can follow the fates of 
each individual cell to better understand the biology of why their survival has 
been selected against in worm development. By purifying these cells (for 
example, using fluorescence-activated cell sorting) we could do single-cell RNA 
sequencing to better understand the identity and function of the undead cells. C. 
elegans has an excellent map of the gene expression of every normal cell type36. 
We could also investigate the fates of these undead cells, observing the type of 
cell they become, any subsequent divisions they may undergo, and whether 
these fates are variable or invariable among worms. While many undead cells 
appear to have neuronal cell features, such experiments would better define 
neuronal and non-neuronal fates adopted by undead cells3,34,37.   
 Finally, we could do a forward mutagenesis screen for mutations that alter 
egl-1 expression, as assessed by GFP signal. egl-1 is normally expressed in the 
131 undead cells. We hypothesize that this specific expression is the result of 
both activating and repressing transcriptional control. Thus, we would expect to 
recover mutants with altered patterns of GFP expression, both increased and 
decreased. These mutations would likely be due to loss of transcription factors 
that act at the egl-1 locus. Relatively gross changes in GFP expression could be 
readily identified by manual examination of large cohorts of worms on plates; 
more subtle abnormalities might be best identified in an automated fashion by 
combining high-throughput, high-resolution imaging of worms coupled with 
automated worm sorting to pull out worms with altered patterns of 
immunofluorescence38. Counter-screens would need to be done to exclude loss 
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of function mutations in gfp or cre (by sequencing these genes via targeted 
sequencing of PCR amplicons), which would also produce loss of GFP signal. 
These screens can identify dominant or neomorphic mutations as well as loss of 
function alleles. Mutagenesis could be performed with EMS, which produces a 
range of DNA alterations including substitutions and indels39. Repeated rounds of 
outcrossing followed by selfing to reproduce the homozygous phenotype would 
eliminate most unlinked mutations, following which whole genome sequencing 
combined with other techniques could be used to identify the causal mutation in 
each mutant strain.  
 
Design of a method to mark cells programmed to die.  
We sought to design a method to produce a permanent mark on undead cells 
that are normally induced to die due to activation of transcription of egl-1. This 
assay needs to address several challenges. First, the assay needs to overcome 
the fact that expression of egl-1 normally leads to cell death, which would leave 
behind no cells to inform what genes had been involved in the activation of egl-1. 
Second, egl-1 may only be transiently expressed in cells during development, 
further complicating the experimental design—a direct reporter of egl-1 
expression may not capture the brief period of expression.   
To address these issues, we sought to genetically prevent cell death by 
mutating egl-1 or ced-3, two genes required for DPCD, thereby allowing survival 
of cells in which transcription of the egl-1 locus had been induced. We further 
sought to permanently mark the cells in which transcription at the egl-1 locus had 
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been activated. We presume this activation typically occurs by factors that 
directly or indirectly promote egl-1 transcription by interaction with flanking 
regulatory sequences.  Permanent marking of these undead cells could be 
achieved with a reporter gene that would be permanently expressed by even 
transient expression at the egl-1 locus. This could be achieved with an indirect 
egl-1 reporter, rather than the direct egl-1 reporters used in previous 
studies32,35,40. Our indirect egl-1 reporter will require two components that make 
use of Cre-Lox recombination: the first is the cre coding region flanked by egl-1 
regulatory sequences, and the second is a ubiquitous promoter driving 
expression of a gfp gene that has been disrupted by LoxP sites. When the egl-1 
regulatory sequence drives even transient expression of Cre, these LoxP sites 
will permanently recombine such that expression of the gfp gene is constitutively 
driven by the ubiquitous promoter to produce a functional green fluorescent 
protein. Successfully engineering such a system would thus allow for a 
permanent visible marker of all cells in which egl-1 is normally expressed.  
 
Methods 
Making a construct to replace the egl-1 coding region with cre recombinase 
via CRISPR/Cas9 
Segments extending from the transcription start site of egl-1 to 60, 100, 300, or 
1000 bases 5’ to the start site were amplified from the genomic DNA flanking egl-
1 using specific PCR primers identified using A plasmid Editor (ApE) program. 
Segments of 60, 100, 300, or 1000 base pairs lying 3’ to the end of the egl-1 
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coding region were similarly amplified and purified. These flanking sequences will 
provide sequences to direct homology-directed repair at the egl-1 locus. A 
plasmid encoding cre recombinase (from Addgene) was used as a cloning 
vehicle. The plasmid was linearized at unique digestion sites either 5’ or 3’ to the 
coding sequence, and the amplified segments of egl-1 regulatory regions were 
sequentially ligated onto the 5’ end and 3’ end of the cre coding sequence using 
DNA ligase, and the resulting clone bearing cre flanked by egl-1 regulatory 
sequences was cloned in the same bacterial plasmid, purified, and the insert was 
liberated from the plasmid by restriction enzyme digestion and purified by 
agarose gel electrophoresis.  
 We used dominant markers for hygromycin resistance and the ‘dumpy’ 
phenotype (shorter, rounder worms) as co-injection markers. These were 
included in the injection mix and introduced as extrachromosomal arrays. This 
enabled visual identification of worms that had undergone germline 
transformation, which could then be further studied for successful CRISPR/Cas9 
replacement at the egl-1 locus. 
Injection mix containing these constructs was injected into gonads of L4-
stage worms, as described below.  
 
Making a construct to replace the egl-1 coding region with Cre 
recombinase via extrachromosomal array integration of a transgene. 
For extrachromosomal linear array production, the same Cre construct was 
made, as described above, with the exception that the 5’ flanking region 
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comprised 1 kb of DNA upstream of the egl-1 transcription start site and the 3’ 
flanking region comprised 5.8 kb of DNA 3’ to the end of the egl-1 transcription 
unit. These flanking regions have been shown to contain sequences critical for 
for proper regulation of the egl-1 gene, although it is possible that additional 
regulatory sequences exist15. The resulting cloned construct was verified by the 
production of the predicted DNA fragments following digestion with restriction 
endonucleases, and the insert was excised from the plasmid and purified for 
injection by agarose gel electrophoresis. 
We used the fluorescent protein mCherry under transcriptional control of 
the myo-2 promoter, which is constitutively expressed in the pharyngeal muscle 
cells, as a co-injection marker. This was included in the injection mix and 
introduced as part of the extrachromosomal array that could subsequently be 
integrated. This enabled visual identification of worms that had undergone 
germline transformation, which could then be further studied for successful 
integration of the egl-1/Cre transgene. 
Injection mix containing these constructs was injected into gonads of L4-
stage worms, as described below.  
 
Making a construct for CRE-dependent expression of GFP via 
extrachromosomal integration of a transgene.  
A plasmid was obtained from Addgene containing the constitutive his-71 
promoter, followed by a rearranged gfp gene, in which exons 2 and 3 are 
inverted and flanked by LoxP sites that are in opposite orientation. As a result, 
11 
 
this construct will not make functional GFP. However, in the presence of Cre 
recombinase, homologous recombination between the two LoxP sites will 
produce the normal GFP open reading frame, resulting in production of functional 
GFP.   
We used the fluorescent protein mCherry under transcriptional control of 
the myo-2 promoter as a co-injection marker. This was included in the injection 
mix and introduced as part of the extrachromosomal array that could 
subsequently be integrated. This enabled visual identification of worms that had 
undergone germline transformation, which could then be further studied for 
successful integration of the egl-1/Cre transgene.   
Injection mix containing these constructs was injected into gonads of L4-
stage worms, as described below.  
 
Worm injections 
 A PC-10 Puller from Narishige Group was used to generate needles from glass 
capillaries for microinjection of DNA into C. elegans gonads. L4-stage worms 
were mounted on injection pads and examined under 40x light microscopy to 
locate the gonad. The gonad was then positioned close to the tip of the needle at 
a perpendicular angle and the worm pushed into the needle until the needle tip 
entered the syncytium, penetrating through the cuticle and the layer of cells 
bordering the gonad. The injection mixture was then injected into the syncytium, 
creating a flow of liquid through the syncytium that can be observed to displace 
the nuclei. Using this technique, the anterior gonad, posterior gonad, or both can 
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be injected. We typically inject approximately 20 animals per session. After 
injections, animals were recovered in M9 and singled to a fresh NGM plate. 
 
CRISPR/Cas9 editing 
For CRISPR/Cas9 replacement of egl-1 with cre, sgRNAs targeting the coding 
region of egl-1 with an appropriate PAM site were identified and obtained from 
IDT. An injection mix of 50 ng/mL of pDD162 (Peft-3::Cas9), 40 ng/mL of the egl-
1 sgRNA, 30 ng/mL per 50 nt dsDNA of repair template, 30 ng/mL of dpy-10 
sgRNA, and 26 ng/mL of dpy-10 repair template, was used for injection into 
gonads of L4-stage worms.  
F1 progenies of the injected parents were examined for dpy-10 
phenotype, and dumpy worms were subject to Sanger sequencing.  
 
Integration of extrachromosomal arrays 
As an alternative to precise genome editing, we also used the egl-1/cre construct 
and the Cre-dependent GFP construct to make extrachromosomal arrays in 
which the DNA constructs, without the sgRNAs, Cas9, or tracr RNA were injected 
as above. 
Extrachromosomal DNAs can replicate and be maintained as stable 
arrays. However, they can also be integrated into the C. elegans genome by 
trimethylpsoralen (TMP) mutagenesis plus UV light, which induces double strand 
DNA breaks, with integration of constructs at breakage sites. For 
extrachromosomal array integration, transgenic animals were treated with TMP 
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solution and illuminated with 30mJ of 365nm UV light. To recover, concentrated 
OP50 was then added to the plates and the animals were stored in the dark for 2 
hours or more.  
Animals showing the pharyngeal mCherry phenotype were selected for 
evaluation of chromosomal integration of the constructs; expression of mCherry 
was taken as evidence of the presence of the transgene arrays.  
 
Mapping integrants to specific chromosomes 
Integration of the transgenes into chromosomes following TMP-UV treatment 
was tested by segregation analysis. Integration into a chromosome can be 
proved by mapping integrants to a specific chromosome via crossing transgene-
bearing worms to mapping strains. In these experiments, mapping strains 
EG1000 and EG1020 were used, each of which bears three visible recessive 
phenotypes on different chromosomes; the two strains collectively mark all worm 
chromosomes, I – V and the X.  
Worms presumptively homozygous for transgenic constructs were crossed 
with worms of the EG1000 and EG1020 strains that were homozygous for all 
three visible phenotypic markers. Resulting F1s were heterozygous at each of 
the visible marker loci and were confirmed to express mCherry by fluorescence 
microscopy.  These worms were then selfed. In the resulting F2’s, worms with 
each visible recessive phenotype were selected and immunofluorescence was 
performed to look for mCherry expression. In the absence of recombination, the 
presence of a visible recessive phenotype such as dumpy due to a mutation on 
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chromosome V should never be accompanied by mCherry fluorescence if 
mCherry is integrated to chromosome V, since both copies of chromosome V 
would have been inherited from the mapping strain and not from the strain 
bearing the mCherry gene. In contrast, if mCherry is integrated instead on a 
different chromosome (e.g., chromosome II), many worms with the dumpy 
phenotype will be positive for mCherry. Thus, anticorrelation of mCherry and a 
recessive phenotype known to lie on chromosome n provides clear evidence that 
mCherry lies on the homologous chromosome. This is further supported by 
finding that recessive phenotypes due to mutations on other chromosomes do 
not show such anticorrelation. Because recombination can occasionally occur in 
the interval between the site of mCherry integration and the location of the 
recessive mutation derived from the mapping strain, anticorrelation may not be 
perfect, but such apparent recombinants should be uncommon, given that none 
of the C. elegans chromosomes comprise more than about 50 centimorgans.    
 
Animals 
Wild-type inbred worms (N2), ced-3 loss-of-function (MT1522) and mapping 
strains (EG1000 and EG1020) of C. elegans were used in this study. 
 
Worm Maintenance 
Worms were maintained on NGM plates seeded with OP50 bacteria. Active 
plates were maintained on the bench top, while master plates were stored in 15-
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degree C and 20-degree C refrigerators. Transfer of worms to new plates was 
performed under a dissection microscope with platinum wire. 
 
Induction of males 
Spontaneous production of male progeny occurs at a low rate under normal 
conditions. When more male progeny were required, we transferred 5 L4 
hermaphrodites of the desired line to new plates and heat shocked them at 34 
degrees C for up to 4 hours. Highest yields of male progeny were produced from 
plates incubated at 34 degrees C for 135 minutes. These males can then be 
crossed with hermaphrodites of the desired strain to produce a stable population 
of males. Plating these worms at a higher ratio of males to hermaphrodites 
increases the likelihood of cross-fertilization over self-fertilization, and thus 
increases production of male progeny. A typical crossing plate might include 12 
males and 4 hermaphrodites. 
 
Freezing C. elegans using liquid freezing solution 
Worms were frozen for indefinite storage in liquid nitrogen according to standard 
protocol41. 
 
Visualization and imaging of worms for GFP fluorescence  
Visualization and imaging of worms was done using fluorescence microscopy 
with the appropriate green and red filters for GFP and mCherry. Images were 
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captured using a spinning disk confocal microscope with worms mounted on 3% 




Our goal was to introduce a permanent visible marker for DPCD. DPCD is 
normally initiated by expression of egl-1. Virtually all cells can be prevented from 
undergoing DPCD by making worms that are null for either egl-1 or ced-3. Since 
all or nearly all cells that undergo DPCD uniquely express egl-1, we can use egl-
1 regulatory sequences to mark the resulting undead cells. A challenge in 
marking these cells is that, due to the transient expression of egl-1, a direct 
reporter of egl-1 expression produces only a transient signal, limiting the scope of 
future experiments to which such a reporter could be employed. Previous 
attempts to build egl-1 reporters result in marking of only a few of the 131 undead 
cells in ced-3 mutants32,35,40.  
To solve this problem, we designed a two-component system in which the 
egl-1 regulatory information drives expression of a gene whose expression in 
turn induces permanent expression of a reporter gene. A way of permanently 
turning on the expression of this reporter gene would be to induce a 
chromosomal rearrangement that creates an intact gene from one that was 
previously incapable of producing a normal protein product.   
This can be accomplished by use of Cre-Lox recombination. The first 
component in our system will use egl-1 cis-regulatory sequences to drive 
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expression of Cre recombinase, such that this enzyme will only be expressed in 
cells that normally express egl-1.  
The second component comprises a constitutively active promoter ligated 
to the coding region of gfp in which several coding exons are in inverted 
orientation so that transcription cannot make the functional GFP protein. These 
inverted exons would be flanked by LoxP sites in opposite orientation to one 
another.  In the absence of Cre, no functional GFP can be produced. However, if 
cre is expressed, it will induce homologous recombination between the LoxP 
sites, which will invert the orientation of the exons lying between the LoxP sites 
and restore an intact and functional GFP. This GFP would then be constitutively 
expressed, thereby providing a permanent mark of cells in which expression at 
the egl-1 locus had been induced.   
By combining these two components, even transient activation of the egl-1 
regulatory sequence in a cell will cause permanent expression of GFP, producing 
a visible marker of undead cells (Figure 2).  
 
Design and construction of the egl-1/cre driver template for CRISPR 
To build a Cre-Lox reporter strain for egl-1, we first sought to build the Cre driver 
component. This strain must be designed in such a way that expression of cre is 
driven by the regulatory sequence of egl-1. One approach to integration of this 
Cre driver component was to use CRISPR/Cas9 to precisely target a double-
strand DNA break and homologous repair such that the coding region of egl-1 
was excised and replaced with the coding region of cre. This approach has the 
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advantage of simultaneously generating the loss of function mutation in egl-1 that 
will abolish DPCD and of integrating the coding sequence of cre under 
transcriptional control of the endogenous egl-1 regulatory sequence.  
 To this end, we made constructs in which homology arms—DNA identical 
to the genomic sequence immediately 5’ and 3’ of the egl-1 transcription unit—of 
varying lengths (60bp, 100bp, 300bp and 1000bp) were ligated respectively to 
the 5’ and 3’ ends of the gene encoding Cre.  
 
Attempted CRISPR engineering of the egl-1 locus to express cre 
We attempted to induce replacement of the egl-1 coding sequence with the cre 
cassette by injecting wild-type (N2) C. elegans in the L4 developmental stage 
with a guide RNA targeting the coding sequence of egl-1, along with Cas9 
protein and the linear fragment bearing the cre cassette flanked by 5’ and 3’ 
regulatory sequences from the egl-1 locus, which would provide homology arms 
to enable homology-directed repair, as described in Methods (Figure 3).  At the 
same time, co-injection markers for induction of hygromycin resistance and 
‘dumpy’ phenotypes were injected as transgenes. In 14 rounds of injections, we 
injected a total of 296 worms, which we designated the P0 generation. 
The F1 progeny were then scored for survival in the presence of 
hygromycin and for having the dumpy phenotype. These provided visible 
markers that germline transformation had occurred. We isolated 271 transgenic 
F1’s originating from 64 P0s. Thus, germline transformation occurred in ~22% of 
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the injected P0s, and when transformation occurred, these P0s produced an 
average of ~4.23 transgenic F1 progenies each.  
Transgenic F1s were then singled to fresh NGM plates and allowed to 
produce F2s. After producing F2s by hermaphrodite self-fertilization, the F1s 
were then individually lysed and their DNA amplified by PCR. To test 
replacement of egl-1 with cre, a forward primer was located within the cre gene 
itself, while a reverse primer was located beyond the homology arm of the 3’ end 
of the insertion construct, thus lying in the native egl-1 locus. PCR amplification 
would then produce products of the proper size only if cre had replaced the egl-1 
gene at the native egl-1 locus. The resulting PCR products were analyzed by gel 
electrophoresis for bands of appropriate length.  
Altogether, we injected 296 worms, resulting in 64 germline 
transformations and leading to the production of 271 transgenic F1 progenies  
with the dumpy phenotype.  We analyzed each of these F1s for cre integration 
and found no evidence for integration. In the course of these experiments, we 
tried modifying our protocol by varying the lengths of our homology arms, but we 
were never able to find evidence of cre integration. There are numerous possible 
explanations for the failure of this approach, which are elaborated in the 
Discussion. 
 




As an alternative approach, we sought to create transgenic worms by integration 
of extrachromosomal arrays rather than via CRISPR/Cas9. For CRISPR/Cas9 
editing we only needed a construct with short homology arms flanking egl-1 
coding regions linked to cre in order to drive homology-directed repair to the 
endogenous egl-1 locus, because once in place the cre sequence would be 
under transcriptional control of the endogenous egl-1 locus. By contrast, for an 
extrachromosomal array, the construct needs to contain regulatory sequences 
flanking the egl-1 locus in order to mimic endogenous egl-1  expression.  We 
therefore first identified the known cis-regulatory sequences for egl-115. This 
comprised 1 kb of DNA 5’ to the start of egl-1 transcription and 5.8kb in the 3’ 
UTR and beyond the end of the coding region. These sequences were produced 
by PCR and were then ligated respectively to the 5’ and 3’ ends of the cre coding 
sequence and purified from cloned constructs (Figure 4). mCherry, expressed 
from the myo-2 promoter, was prepared for co-injection with this construct.   
 
Generation of transgenic lines carrying the egl-1/cre construct as an 
extrachromosomal array 
We injected the egl-1/cre construct, along with the dominant mCherry as a visible 
co-injection marker, into the gonads of 20 L4-stage ced-3 loss-of-function mutant 
worms as described in Methods. After injections, we allowed these P0 worms to 
self-fertilize and produce progeny (F1s). We performed a visual screen for 
presence of the mCherry co-injection marker to identify worms bearing the 
extrachromosomal array in the F1 generation. We identified 65 transgenic F1s 
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originating from 9 P0s. We singled 15 transgenic F1s to fresh plates and scored 
their F2 progeny for percent expression of the mCherry marker. From these, we 
selected lines in which 30-70% of the worms carried the mCherry marker, 
presumably as an extrachromosomal array. Lines with this level of transgene 
maintenance were good candidates for attempts to integrate the arrays into 
chromosomes by induction of double strand breaks, as described in Methods.  
 
Chromosomal integration of the extrachromosomal array egl-1/Cre 
construct 
Following selection of these lines, 10 F2s from 3 lines were singled and 
expanded for mutagenesis of >100 worms in the F3 generation. Once these F3s 
reached the L4 developmental stage, they were mutagenized with 
trimethylpsoralen treatment and exposure to UV radiation, as described in 
Methods. This mutagenesis introduces random double-strand breaks to the DNA, 
providing a substrate for integration of the extrachromosomal array at these sites 
in the genomes of gametes by non-homologous end-joining. At the doses of 
mutagen used, it is expected that integration will not occur in most gametes, and 
that there will rarely be more than one integration event per genome. After 
recovering the mutagenized L4 worms, 10 of these L4s (now considered the P0 
generation for the following experiments) were picked to each of 13 fresh master 
plates, where they  produced progeny (F1s).  
Plates were then stored in 20-degree C incubators and starved. When 
starved, C. elegans larvae arrest, either at the L1 stage—in which they remain 
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viable for a couple of weeks—or in an alternative ‘dauer’ stage—in which they 
remain viable for a couple of months. From each of these starved plates, a chunk 
approximately 25mm x 25mm of the NGM containing these larvae was then 
transferred to  plates freshly seeded with OP50, and the worms allowed to 
reproduce. This process of starving, chunking, and reproducing was repeated 
once more. It is expected that among the resulting progeny will be marker-
positive integrants heterozygous for the transgene, some marker-positive 
integrants homozygous for the transgene, and non-integrants that may yet exhibit 
marker positivity due to continued transmission of the extrachromosomal array.  
From each of these plates, 20 marker-positive L4s were picked and 
singled, tracking from which master plate each worm derived. While it is possible 
to have more than one integration event among the 10 P0s originally picked to 
each master plate, because integration is a rare event, each population deriving 
from the 10 independent P0s picked to each of the 13 master plates likely 
contains no more than one integration event. We call the F1 animal that originally 
contained this integration the ‘founder’.  
In addition to true integrants, some of the singled marker-positive L4s will 
merely contain the original extrachromosomal transgene. If that is the case, 
because the transgene is unstable, we expect that not all of their progeny will be 
transgenic. However, if chromosomal integration is present in the population, and 
if we pick an animal that is homozygous for the integrated transgene, 100% of 
the offspring of these worms will express the mCherry marker. We singled 260 
worms deriving from 13 master plates. Screening of their offspring for those in 
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which 100% showed expression of mCherry demonstrated 17 putative integrants 
derived from 9 separate master plates. This provided evidence of multiple 
independent integrants for the egl-1/cre construct. 
 
Generation of Cre-dependent GFP reporter strains 
In parallel, we produced another construct in which the gene encoding 
GFP was ligated downstream of the ubiquitously active his-71 promoter. As 
described in Methods, exons 2 and 3 of the gene were inverted and flanked by 
inverted LoxP sites. Thus, functional GFP cannot be produced from this 
construct, and will only be produced if Cre induces recombination between the 
two LoxP sites, flipping exons 2 and 3 into the proper orientation (Figures 5). As 
above, mCherry linked to the myo-2 promoter was co-injected to provide a visible 
marker demonstrating germline transformation. 
We injected this linear Cre-dependent GFP construct, along with the 
dominant mCherry as a visible co-injection marker, into the gonads of 20 L4-
stage worms homozygous for the ced-3 loss-of-function mutation, as described in 
Methods. After injections, we allowed these P0 worms to self-fertilize and 
produce progeny (F1s). Using the presence of the co-injection marker (mCherry) 
we performed a visual screen to determine successful introduction of our 
extrachromosomal array in the F1 generation, identifying 48 transgenic F1s 
originating from 7 P0s. 15 transgenic F1s were singled to fresh plates, and their 
F2 progeny were scored for percent expression of the mCherry marker. From 
these, we selected lines showing 30-70% stable transgenicity—ensuring enough 
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transgenic animals for subsequent integration by TMP mutagenesis, while still 
allowing for discrimination between possible integrants and extrachromosomal 
arrays. 
 Following selection of these lines, 10 F2s from 3 lines were singled and 
expanded for mutagenesis of >100 worms in the F3 generation. Once these F3s 
reached the L4 developmental stage, they were then mutagenized with TMP 
treatment and exposure to UV radiation as described in Methods. After 
recovering the mutagenized L4 worms (now considered the P0 generation in the 
following experiments), 10 of these L4 P0s were picked to each of 13 fresh 
master plates, where they were allowed to produce progeny.  
Plates were then stored in 20-degree C incubators and starved. From 
these starved plates, a chunk of the NGM containing arrested larvae was then 
transferred to a set of freshly seeded plates, and the worms allowed to 
reproduce. This process of starving, chunking, and reproducing was repeated 
once more. From each of these plates, 20 L4s were singled, tracking from which 
master plate each worm derived.  
We then examined the progeny of these singled animals, screening for 
plates in which 100% of progeny expressed the mCherry co-injection marker, 
consistent with the parent worm being homozygous for the transgene. Plates in 
which 100% of progeny were transgenic were considered putative homozygous 
integrants.  
260 worms were singled from 13 master plates. Screening of the offspring 
of these 260 worms for 100% expression of mCherry demonstrated 19 putative 
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integrants derived from 6 separate master plates. This provided evidence of 
multiple independent integrants for our Cre-dependent GFP reporter. 
 
Testing and mapping of integrants for egl-1/cre 
Although 100% segregation of the transgene is strong evidence of 
chromosomal integration, it is possible that this is caused by extragenic 
stabilization of the array rather than integration. To confim integration, we first 
assessed the behavior of each putative integrated transgene in an outcross. We 
expect that integrated transgenes will segregate in a Medelian pattern, while 
extrachromosomal arrays will not. Putative homozygous integrants (P0s) 
identified above were crossed with wild-type N2 males. Transgenic male progeny 
of this cross (F1s) were then selected and crossed with wild-type N2 
hermaphrodites. From the resulting F2s, there are three alternative outcomes. If 
the transgene is integrated on the X chromosome, we expect 100% of the 
mCherry positive progeny to be hermaphrodites, with zero males being mCherry 
positive. If the transgene is integrated onto an autosome, it will segregate 
independently of the X chromosome, so the proportion of mCherry positives that 
are males or hermaphrodites should not significantly deviate from 50% for each. 
In either case, the F2 hermaphrodites should be heterozygous and, when selfed, 
classic Mendelian proportions should be observed.  
If the transgene array has not integrated, the results are more complex, 
because during meiosis in males (which have a single X and no Y), unintegrated 
transgenes often segregate away from the unpaired X, resulting in sperm that 
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either have an X or have the transgene, but not both. In this case, transgene 
positive offspring will be significantly more frequently male than hermaphrodite. 
Moreover, the finding that transgene positive worms are hermaphrodites less 
than 100% of the time excludes X linkage, while the finding that significantly 
fewer than 50% transgenic worms are hermaphrodites makes autosomal linkage 
unlikely, pointing to absence of integration of the transgene. 
We performed this test by picking ~40 mCherry-positive progeny from nine 
F1 crosses and determined the number of males and hermaphrodites for each. 
The results of these studies identified 7 strains very likely to have integration of 
the elg-1/cre construct (Table 1). Five of these showed no significant departure 
from a 50-50 sex ratio among mCherry positive offspring by chi-square analysis, 
with no strong bias toward males, consistent with autosomal integration. Two 
showed 100% hermaphrodites among mCherry positives, consistent with X 
chromosome integration. The other two showed significantly more mCherry-
positive males than hermaphrodites (p = 0.0008 and p = 0.006 by chi-square 
analysis), providing evidence of non-integration of the transgene array. These 
latter two lines were excluded from further analysis.  
To confirm and extend these results, we performed genetic mapping of 
each integrant, with the goal of mapping it to a specific chromosome. This is 
important not just for establishing integration, but is critical for subsequent strain 
construction in which we seek to make triply homozygous worms for ced-3 loss 
of function (ced-3 is located near the end of chromosome IV, allowing for 
recombinant events with transgenes on chromosome IV), the egl1-cre transgene, 
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and the Cre-dependent GFP transgene. Having our transgenes on separate 
chromosomes is essential to making the triply homozygous strains by simple 
crosses.  
We performed a mapping experiment using the mapping strains EG1000 
and EG1020, as described in Methods. Each mapping strain contains three 
recessive mutations resulting in three visible phenotypes. Each mutation is on a 
different chromosome, and thus the two strains collectively the six C. elegans 
chromosomes, autosomes I - V and the X chromosome.  The first step of 
mapping is to cross the mapping strain with the integration to be mapped. The 
resulting F1 animals will be compound heterozygotes. For the chromosome that 
the integration is on, one homolog will have a mapping mutation and the other 
will have the integration. When these F1s are selfed, the recessive phenotype 
corresponding to that mapping mutation should be significantly anticorrelated 
with the presence of the integrated mCherry transgene. If integration has 
occurred on, for example, chromosome V, nearly all worms with a recessive 
visible phenotype due to mutation of a gene on chromosome V should almost 
always be mCherry negative, with the only exceptions being meiotic 
recombinants. In contrast, if the integrant is not on chromosome V, worms with a 
recessive visible phenotype due to mutation of a gene on chromosome V should, 
on average, be mCherry positive 75% of the time (since mCherry is 
heterozygous in the self-fertilizing parent).  
The seven putative homozygous integrant strains were crossed with each 
of the two mapping strains to produce F1 offspring heterozygous at each test 
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locus. F1s were then selfed to produce F2s. Worms with visible recessive 
phenotypes from each selfing were selected, and expression of mCherry was 
evaluated by fluorescence microscopy. To have sufficient power to map putative 
integrants, for each cross we sought to produce an average of 30 worms with 
clear evidence of each visible recessive marker, and then scored the presence or 
absence of the mCherry marker in each. This typically entailed the screening of 
several hundred offspring of each cross to identify the desired number of worms 
with each visible recessive phenotype, with a cross to each of the two mapping 
strains for each putative autosome integrant, and a cross to the EG1020 strain 
for each putative sex chromosome integrant.  
The presence or absence of mCherry was determined in worms with each 
of the recessive visible markers for all seven strains tested, and the results are 
shown in Table 2. The results demonstrate clear evidence of independent 
integrants, with autosomal integrants showing far less than the 75% mCherry 
positivity expected by chance. The results showed one integrant on chromosome 
II, two on chromosome V, and one on the X chromosome. The remaining two 
strains showed no significant evidence of integration on any chromosome. 
An illustrative example is the strain from master plate 4.16. In this cross 
(Table 2), 30 worms were scored that had the visible recessive dumpy phenotype 
due to mutation on chromosome V. 29 of these did not have the mCherry 
phenotype, whereas only one did (3% mCherry positive). This is a highly 
significant departure from the 75% mCherry positivity expected if mCherry were 
on a different chromosome (chi square, 1df = 82.1, p < 0.00001). In contrast, 
29 
 
none of the other chromosomes showed a significant departure from the 
expected occurrence of mCherry in conjunction with a recessive visible 
phenotype. Moreover, in this same line (4.16) among all chromosomes other 
than chromosome V,  mCherry was collectively found in 114 of 148 worms with 
recessive visible phenotypes (77%), very close to the expected value of 111 
(75%). These results collectively provide extremely strong evidence of integration 
of the transgenic array to a single chromosome, chromosome V. Similar results 
were found for the three other mapped integrants on chromosomes II, V and X, 
while there was no strong evidence of integration for the three other tested lines. 
 
Testing and mapping of putative integrants for Cre-dependent GFP 
constructs.  
Analogous analysis testing for integration and mapping of integrants for the Cre-
dependent GFP construct was performed as was done for the egl-1/cre 
construct. Six strains putatively homozygous for this transgene, as identified 
above, were crossed with wild-type N2 males. Male progeny of this cross (F1s) 
were then selected and crossed with wild-type N2 hermaphrodites. ~40 
mCherry–positive progenies were scored for their sex. The results are shown in 
Table 3.  In one line, 100% of mCherry-positive worms were hermaphrodites, 
providing evidence of integration on the X chromosome. Three lines showed no 
significant departure from an equal sex ratio among mCherry-positive progeny, 
suggestive of autosomal linkage. The other two lines showed a strong but 
incomplete bias toward male gender among mCherry-positive progeny (89% and 
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77%), effectively excluding linkage to either the X chromosome or autosomes. 
These latter two strains were excluded from further analysis as being likely non-
integrants.  
The four remaining promising lines were crossed to the mapping strains 
and analyzed as described above. The results are shown in Table 4. We 
identified three independent integrants, one each on chromosomes II, IV and X, 
with one line not providing significant evidence of integration.  
 The results of these experiments identified independent integrants of both 
transgenes, with integration occurring on sufficiently diverse chromosomes that 
worms simultaneously homozygous for ced-3 loss of function, the egl-1/cre 
construct, and the Cre-dependent GFP construct can be made by simple 
crosses.  
 
Recovery of worms triply homozygous for transgenic egl-1/cre, transgenic 
Cre-dependent GFP and ced-3 loss of function. 
Outcrossing while selecting for our desired transgenes has the benefit of 
decreasing the frequency of deleterious mutations that might have occurred as a 
consequence of TMP mutagenesis, and which may decrease the viability of the 
animals. Each of our putative integrants was outcrossed twice with the wild-type 
N2 strain, and each strain that demonstrated integration by mapping was 
outcrossed twice more with a ced-3 knockout strain. 
A consequence of outcrossing was loss of homozygosity of our integrated 
transgenes and of the ced-3 mutation. Therefore, after successful outcrossing, 
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we performed crosses to produce worms that were triple homozygotes for egl-
1/cre, Cre-dependent GFP, and the ced-3 mutation. We started by selfing worms 
that were doubly heterozygous for egl-1/cre and ced-3 on different 
chromosomes. It was expected that 1/16 ( ~6%) of the F1 offspring would be 
homozygous at both loci. To identify these, individual F1 worms were selfed and 
their progeny were first screened for broods in which 100% expressed the visible 
marker mCherry linked to the egl-1/cre locus, which will only occur if the F1 
parent was homozygous at the egl-1/cre locus. This result was found in about 
25% of the progeny of selfed F1’s, consistent with expectation.  
These egl-1/cre worms were selected and selfed again and screened by 
PCR for worms whose offspring were all homozygous for the ced-3 mutation. 
Genotypes at ced-3 were determined by amplification of the segment of ced-3 
that contains the null mutation, which destroys an ApE-KI restriction 
endonuclease cleavage site. Thus, digestion of the segment following PCR will 
produce a wild-type product that is cut into two fragments by ApE-KI, but a 
mutant product that will not be cut. This allows ready discrimination of 
homozygous wild-type, homozygous mutant, and heterozygous worms. Offspring 
of worms that are either homozygous mutant or heterozygous will produce either 
100% homozygous mutant offspring or offspring that are 75% non-homozygous 
mutant. Thus, by genotyping four offspring of each selfing worm, finding that all 
are homozygous mutant for ced-3 provided strong evidence that the parent was 
homozygous mutant, since this result is 256-fold more likely to have resulted 
from a homozygous mutant parent than a heterozygous parent (odds ratio 
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1/(1/4)4).  This effort identified many clones that were doubly homozygous for the 
egl-1/cre transgene and ced-3 mutation (Figure 6).   
To produce worms that were also homozygous at the Cre-dependent GFP 
locus, worms that were homozygous at this locus were produced in parallel by 
the analogous approach above, using the linked mCherry as a visible marker. 
This identified F2 offspring that, when selfed, produced 100% mCherry positive 
worms. These two homozygous lines were then crossed with one another, 
selfed, and their progeny screened for lines that only produced worms 
homozygous at all three loci. We ultimately made triply homozygous lines with all 
possible pairs of sites of integration of each of the two transgenic insertions, 
resulting in 10 genetically distinct permutations. 
 
Expression of GFP  
The test for the efficacy of our genetic engineering of these lines was to look for 
GFP expression in triply homozygous worms. GFP should only be expressed if 
ced-3 is homozygous mutant, thereby producing undead cells, AND Cre is 
expressed under egl-1 regulatory control, AND Cre expression produces 
rearrangement at the Cre-dependent GFP locus. Importantly, if worms are 
homozygous at all three loci, 100% of the progeny of selfing should express 
GFP.  
Figures 7 and 8 show the results. In the absence of these constructs, 
worms show no significant green fluorescence signal other than in gut granules. 
In preliminary examination of two independent triply homozygous lines, all worms 
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showed many cells expressing GFP in the head. These are concentrated in 
green fluorescence-tagged cells in the posterior bulb, which includes the densely 
innervated head ganglion, as well as more rostral cells in the isthmus and 
corpus. These preliminary results provide evidence that the desired strains have 
been made, and that both transgene constructs function as expected. 
 
Induction of males and freezing of final strains 
From strains triply homozygous for egl-1/cre, Cre-dependent GFP, and ced-3 
mutation, stage L4 worms were picked and heat shocked to generate males that 
could be used for crosses in future experiments. These strains were then either 
plated for immediate use or short-term storage in a 15-degree C incubator, or 




The biochemical pathway that produces programmed cell death in the 
development of C. elegans is well-defined; however, the upstream regulators of 
egl-1—the gene that initiates the process—are largely unknown.  We have 
engineered the genome of the worm C. elegans to devise a method that can be 
used to visualize undead cells. This system could provide the foundation for 
studies of undead cell lineage and function, as well as genetic screens to identify 
genes responsible for the induction of egl-1, which would be an important step 
toward a complete understanding of how cells are specified for programmed cell 
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death. Because the programmed cell death pathway is highly conserved among 
all animals, including humans, understanding the regulators of this process in C. 
elegans can provide important insights into the fundamental biology regulating 
this process.  
In our experiments, we introduced two transgene cassettes by germline 
injection into a strain of C. elegans homozygous for a ced-3 loss-of-function 
mutation, such that cells do not undergo programmed cell death in development. 
One cassette links the 5’ and 3’ regulatory elements that flank the normal egl-1 
gene to cre recombinase, while the other has a green fluorescent protein (GFP) 
reporter that is permanently expressed by genomic rearrangement if Cre is even 
transiently expressed. These cassettes were transmitted to progeny as stable 
extrachromosomal arrays, then randomly integrated to chromosomes by TMP/UV 
mutagenesis, as confirmed by segregation/co-segregation data in our mapping 
experiments. 
We succeeded in producing four independent genomic insertions of the 
egl-1/cre cassette and three with the Cre-dependent GFP cassette. We made 10 
strains that had different combinations of the egl-1/cre and Cre-dependent GFP 
cassettes and made each triply homozygous for these plus the ced-3 loss-of-
function mutation. Preliminary work provided evidence of Cre-dependent 
expression of GFP in two of these lines. These preliminary results suggest that 
GFP expression reproducibly labels many cells in the worm’s head, specifically in 
the posterior bulb, the isthmus, and the corpus, with no reproducible signal 





The mapping strategy used to demonstrate independent chromosomal integrants 
was very successful. Nonetheless, a number of crosses and production of many 
progeny was required to map each locus. In the time since this work was 
performed, longer-read genomic DNA sequencing has become more available 
and less expensive, suggesting use of brute-force genomic sequencing to 
identify chromosomal integrants may be preferable. Long reads can be done by, 
for example, PacBio sequencing, employing highly processive polymerases that 
can read the same sequence repeatedly to routinely achieve ensemble 
consensus reads that are highly accurate, with read lengths of 10s of thousands 
of base pairs42. These long reads are sufficient to unequivocally identify the 
sequence joining integrants to chromosomal DNA, enabling rapid assessment of 
integration sites at base-pair resolution. An additional benefit is the ability to 
determine whether there are companion mutations that might be deleterious. 
Because TMP/UV mutagenesis creates insertion-deletion mutations, they can be 
readily identified with high-quality sequence, and the inference as to whether 
mutations in coding regions are functionally significant is considerably clearer for 
insertion/deletion mutations than for induced point mutations. The small size of 
the C. elegans genome gives this or analogous approaches (e.g., “10x 
fragmentation” sequencing43 or nanopore sequencing—in which single bases are 
read as they are drawn through a pore, such as occurs when DNA is packaged 
into a viral capsid)44 the potential to permit direct identification of integrants 
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without the time required for performance of the crosses needed for analysis of 
co-segregation. 
While our efforts at genetic engineering ultimately proved successful using 
extrachromosomal array integration, we initially attempted to use the 
CRISPR/Cas9 system for this purpose. The reason our CRISPR/Cas9 editing 
was unsuccessful is not entirely clear. In these experiments, because not all 
injections will produce germline transformation, it is highly useful to have a 
concurrent positive control for germline transformation—if this DNA has entered 
the germline and been transmitted to an offspring, other co-injected DNAs are 
empirically highly likely to have accessed the same germline nuclei. If this 
positive control can be scored by visible inspection of the worm, one can readily 
focus on these worms to assess whether the desired correction introducing cre 
into the germline has occurred. In our CRISPR experiments, the dominant 
marker dpy-10 proved to be very useful as an independent marker of 
transformation, indicating that injected DNA was reaching the nucleus of 
germline cells. Because we produced many progenies exhibiting the ‘dumpy’ 
phenotype, we can be confident that our CRISPR cassette was reaching the 
germline, and that failure to do so was not the cause of our apparent failure to 
achieve successful repair with our cre template. 
Ultimately, the cause of this failure eludes us. While the length of the non-
homologous sequence being inserted was longer than, for example, a very short 
‘patch’ carrying a desired homologous insertion, insertions as long as the one we 
sought to make have been successfully inserted into the worm genome, though 
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with low efficiency. Nonetheless, achieving the needed molar concentration of a 
construct several kilobases in length versus one only 30 base pairs in length 
could make success harder to achieve, particularly with a long segment of non-
homology. Another potential explanation for this failure could be biological. It is 
possible that complete loss of function for egl-1 might be lethal or severely impair 
reproductive fitness. To this point, Horvitz and colleagues noted in their 1998 
paper describing the cloning of egl-1 that complete nulls for this gene had never 
been discovered and loss of function mutations identified in genetic screens had 
never been clear nulls, i.e., deletions, frameshifts or premature termination 
mutations, suggesting these could, in fact, be lethal15.  
 
Future experiments 
Chromosome engineering in C. elegans is clearly extremely powerful, permitting 
complex manipulation of genes and regulatory elements to allow increasingly 
incisive questions to be asked about the regulation of fundamental biological 
processes such as developmental programmed cell death.  
In our experiments, we sought to create a system that would permit large-
scale, unbiased screening for mutations that fail to normally induce expression of 
egl-1, a gene whose expression normally initiates a cascade of events that result 
in programmed cell death of particular cells in development. The signals that 
induce egl-1 expression are largely unknown, leaving open the question of how 
the system is programmed and controlled. This is an important question both 
because of the role of DPCD in vertebrate development—for example in 
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modeling distinct digits from an otherwise webbed hand or foot45—and because 
of the role disruptions to the cell death pathway play in human pathology—for 
example, understanding how to induce apoptosis in cancer cells that often are 
protected from apoptosis via overexpression of Bcl-246 (a ced-9 homolog) could 
be of clinical use. Genetic manipulation of C. elegans is extremely well-suited for 
dissecting the regulation of programmed cell death owing to the ease of genetic 
manipulation, small genome size with few paralogs of most genes, and short 
generation time with ability to produce and score phenotypes in hundreds to 
thousands of worms. 
The next steps envisioned would be to characterize the cells that are 
reproducibly labeled by GFP in independent strains. Our preliminary work 
identified many cells in the head; autofluorescence in gut granules made an 
assessment of posterior structures more challenging. The lineage of each of the 
undead cells identified should be traced, permitting determination of whether all 
the marked cells are cells that normally die in development. Imaging of 
developing embryos using a dual-view inverted selective plane illumination 
microscope (diSPIM) that allows for volumetric time-lapse imaging can be 
performed, employing annotation software to map the lineage of the cells 
throughout embryonic development. This data can be used to determine where in 
the cell lineage GFP expression is activated, and whether it is present in all cells 
known to undergo programmed cell death. 
Finding that marked cells comprise all 131 cells that normally undergo 
DPCD and no others would clearly implicate egl-1 expression in all DPCD, while 
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labeling of a subset of these cells would indicate that there are likely be other 
pathways for activation of DPCD. Expression of GFP outside the 131 
‘developmental undead cells’ could occur for several reasons. First, Cre 
expression could be ‘leaky’ – expressed for reasons other than induction by egl-1 
regulatory sequences. This could occur as a consequence of the location of 
insertion into the genome; for example, Cre could be expressed under the 
influence of other nearby regulatory sequences. In this case, we would expect 
the result to vary in strains with independent insertions of the egl-1/cre cassette 
in different chromosomal locations. Second, studying post-embryonic or adult 
worms could increase the number of ‘undead’ cells beyond the 131 
developmentally targeted cells, as could occur via induction of apoptosis due to 
stochastic damage. This is a consequence of the ced-3 mutation, which would 
result in all cells induced to undergo apoptosis to become ‘undead’; expression of 
egl-1 in any of these would cause them to be labeled with GFP. These additional 
apoptotic events could accumulate over the life of the worm. Consequently, 
studying worms at earlier stages would likely better restrict the signal to 
developmentally undead cells. This would be feasible, since 118 of the cells that 
are programmed to die in development do so during embryogenesis, while 13 die 
in post-embryonic development47.  
For the most promising strains, the final constructs could be readily 
verified by whole genome sequencing using long-read technology, as with 
PacBio sequencing; this would enable capture of the boundaries between 
insertions and flanking genomic DNA and identify any peculiarities to the 
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insertion events (e.g., other local genomic alterations). Determining the number 
of developmentally undead cells that are reproducibly labeled would be important 
to understand in considering going forward with a mutagenic screen to identify 
mutations that alter the pattern.  
Projects that could be immediately pursued from having a large set of 
undead cells marked with GFP would include characterization of the cell types of 
each of the undead cells. Many, but not all of these are believed to be neurons. 
Now that there is comprehensive single-cell transcriptome data on C. elegans 
cells, and combinatorial indexing has made production of large single-cell 
transcriptome data sets inexpensive, isolating GFP-labeled cells by fluorescence-
activated cell sorting followed by single-cell sequencing would rapidly allow 
characterization of the cell type of each undead cell36. This could provide insight 
into their normal function and why they are always specified to die (i.e., what 
function do they provide that is eliminated by their death). Insight into this 
functional question can also be pursued by simply following the fate of these 
undead cells that have lineage tracing.  
Similarly, because of the challenge in past efforts to identify and follow all 
cells that normally undergo DPCD, mutations that have been shown to impair 
DPCD of a small number of cells could be involved in DPCD of other cells that 
were simply missed in prior analyses. Having a visible marker for all undead cells 
would greatly simplify the study of the production of specific undead cells when, 
for example, a transcription factor used in some cells to activate egl-1 is mutated.  
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 Returning to a long-term goal of the project—to proceed to systematic 
TMP-UV mutagenesis to identify novel genes whose mutation would eliminate 
the signal from undead cells or reproducibly cause aberrant signal in cells that do 
not typically undergo programmed cell death. This is a challenging project, as it 
would require being able to score individual undead cells as being positive or 
negative for expression of GFP. If this was feasible, mutagenesis with TMP-UV in 
a highly inbred genetic background would be ideal for making and identifying 
mutations. Because the TMP mutagen makes small to medium-sized deletions, 
once phenotypic mutants have been identified that reproducibly knock out 
expression of reporter GFP in one or more undead cell types, the mutated gene 
could be quickly identified by brute-force whole-genome sequencing of worms 
with the mutant phenotype. Mutations that substantially and reproducibly reduce 
the number of undead cells produced in an embryo would likely be easiest to 
recognize; the robustness and consistency of labeling of undead cells in 
development would determine the level of resolution the mutagenesis approach 
could have. Because experiments are done in an inbred background, the 
sequencing of the starting strain should ostensibly be invariant, and, by 
sequencing a small number of segregants, the finding of the same mutation in 
worms that share the same mutant phenotype would provide strong evidence 
linking mutant genotype to mutant phenotype. From this starting point, this 
mutation could be studied in the wild-type background to demonstrate 
unequivocally which specific cells that normally undergo programmed cell death 
in development fail to undergo apoptosis, proving the relevance of the mutation. 
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Important to this effort would be optimizing the dosage of mutagen so that 
sufficient numbers of interesting mutations are produced, but not so large that 
mutagenized worms frequently have impaired reproductive fitness, and also a 
small enough number that outcrossing the mutants can eliminate a sufficiently 
large number of background mutants that sequencing of even a few related 
progenies that share the mutant phenotype will share only one or a small number 
of candidate mutations. These could readily be confirmed as causally related to 
the observed phenotype by making independent CRISPR/Cas9 knockouts of the 
mutated gene and assaying the effect on GFP expression in undead cells.  
If the mutated genes identified proved to be transcription factors, then their 
mechanism of egl-1 regulation could be further elucidated by identifying their 
DNA binding sites, either by searching for the presence of cognate binding motifs 
at the egl-1 locus for that transcription factor, if they are known, or by performing 
ChIP-Seq on developing embryos to identify DNA sequences bound by the 
transcription factor. Binding sites will then be confirmed as egl-1 cis-acting 
regulatory elements by editing their sequence using CRISPR and measuring its 
effect on egl-1 expression using the egl-1 reporter system. Other types of 
regulatory factors (e.g., histone modifying enzymes, microRNAs) would require 
analysis tailored to the specific gene products at each mutated locus.  From 
these starting points, determination of the mechanism that produces expression 
of the identified gene in cells programmed to die would be of interest. Given that 
many of these are neurons, it would be of interest to study whether neuronal 
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firing or other distinctive aspects of neuronal function are drivers of activation of 















Figure 1.  The C. elegans apoptosis pathway. The C. elegans genes in the canonical programmed cell 
death pathway are indicated, and the paralogous gene families that carry out the same functions that are 
found in humans and other metazoans are indicated in parentheses. Expression of egl-1 is rate-limiting for 
activation of apoptosis. Its expression inhibits activity of ced-9, which normally prevents ced-4 from 
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Figure 2.  Marking undead cells with GFP. A schematic of the assay engineered to permanently mark 
‘undead’ cells is shown. Induction of transcription via normal regulators of expression at the egl-1 locus 
leads to production of mRNA encoding the CRE recombinase protein. CRE recombinase then induces 
recombination between inverted LoxP sites, flipping the orientation of exons 2 and 3 of the GFP gene to 
their correct, in-frame orientation. This gene is constitutively expressed under control of the his-71 promoter, 
thereby continuously producing GFP. Cells expressing GFP are readily identified by their bright green 
immunofluorescence. This assay thus provides a permanent GFP mark in cells in which the normal 
transcriptional program for induction of egl-1 was activated. Because the pathway for EGL-1-induced cell 
death is blocked by mutation of ced3, cells that normally die by DPCD survive as ‘undead’ cells and are 




























Figure 3. Design of CRISPR/Cas9 approach to putting Cre recombinase under control of egl-1 
regulatory elements. At the top of the figure, the general structure of the genomic egl-1 locus is depicted, 
with the coding region flanked by 5’ and 3’ regulatory elements. Below, a replacement cassette in which the 
coding sequence of Cre recombinase has been ligated to the 1kb of sequence that lies immediately 
upstream and downstream of the egl-1 locus is shown. This cassette, along with a 20 base guide RNA 
homologous to egl-1 coding region that directs the Cas9 endonuclease (along with Tracr RNA) to make a 
double stranded cut in egl-1 coding region, is injected into the gonad of L4-stage worms. Recombination 
between the homologous sequences 5’ and 3’ of the genomic egl-1 locus and those of the repair template 
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Figure 4. Design of extrachromosomal array putting Cre under control of elg-1 regulatory sequences 
with mCherry. The coding region of the Cre gene has been ligated to 1 kb of 5’ flanking sequence upstream 
of the egl-1 coding region, and 5.8 kb of 3’ flanking sequence distal to the egl-1 coding region. The resulting 
fragment was cloned into bacterial plasmids, grown and the construct liberated by restriction endonuclease 
digestion and purified by gel electrophoresis. The mCherry gene linked to the myo-2 promoter was similarly 
purified. These were injected together into the gonads of L4-stage worms. Putative transformants were 
identified by mCherry fluorescence; these worms were treated with trimethylpsoralen plus UV light to induce 
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Figure 5. Design of extrachromosomal array with Cre-dependent GFP and mCherry. A plasmid insert 
containing the GFP gene with exons 2 and 3 in inverted orientation flanked by LoxP sites in inverted 
orientation was purified and injected into gonads of L4 stage worms along with the mCherry gene expressed 
under control of the myo-2 promoter. Putative transformants were identified by mCherry fluorescence and 
treated with trimethylpsoralen plus UV light to induce chromosomal integration of the array. In worms 
bearing this array, cells that express Cre recombinase will produce recombination between LoxP sites, 







Figure 6. Determination of wild-type and loss of function alleles of ced-3.  Wild-type and loss of 
function alleles of ced-3 can be distinguished by the respective presence or absence of a cleavage site for 
the restriction enzyme ApE-KI that is abolished by the ced-3 loss of function mutation. PCR amplification of 
a segment of the coding region that includes the segment bearing the ApE-KI site, followed by treatment 
with the ApE-KI enzyme, produces two fragments from wild-type alleles (red arrows) and the uncut product 
from the mutant ced-3 (blue arrows). The genotype of a worm can be determined by analysis of agarose gel 
electrophoresis of the products of digestion of these PCR amplicons. The figure shows a gel of such 
products from 18 worms. The presence of a single large band in a column signifies a worm homozygous for 
the mutant ced-3 (blue bracket), while the presence of all three bands in a column signifies a worm 














Figure 7. Anatomy and Nervous System of C. elegans.  
A. Graphic representation of the anatomy of the C. elegans head. At the anterior end, the pharynx is 
connected to the buccal cavity. At the posterior end, it is connected to the intestine through the pharyngeal-
intestinal valve (vpi). The posterior bulb contains dorsal, ventral, and lateral ganglia. Image adapted from 












































Figure 8. GFP expression in L4-stage C. elegans homozygous for egl-1/Cre; Cre-dependent GFP; 
ced-3 lf mutant. Pictured are C. elegans homozygotes for egl-1/Cre; Cre-dependent GFP; ced-3 lf mutant in 
the L4 developmental stage imaged under a green fluorescent filter. Images capture the anatomic regions 
from the buccal cavity to the pharyngeal-intestinal valve (vpi). Each image is a merged Z-stack of a unique 
animal. Images A through D originate from Line 1 (egl-1/Cre 4.16 x Cre-dependent GFP 5.14), and images 
E and F originate from the genetically independent Line 2 (egl-1/Cre 11.6 x Cre-dependent GFP 8.2). We 
observe a reproducible pattern of GFP signal in cells of the posterior bulb and corpus, with particularly high 
signal in the posterior bulb, where the dorsal, ventral, and lateral ganglia are located. The presence of auto-
fluorescent “gut granules” are abundant in the intestine, seen in image B. There were no obvious cells distal 






Table 1. Characterization of putative egl-1/cre integrants crossed with N2 wts
Putative homozygous integrants (P0s) were crossed with wild-type N2 males. Transgenic male progeny of this cross 
(F1s) were then selected and crossed with wild-type N2 hermaphrodites. mCherry-positive progenies from each of the 
nine F1 crosses were picked and scored for percent males and percent hermaphrodites. Results are shown in the 
above table. 100% of mCherry-positive progeny being hermaphrodites indicates a likely integration on the X 
chromosome. Approximately 50% transgenic progenies being male and 50% hermaphrodites indicates a likely 
integration on an autosome. Transgenic progeny that are significantly more male than hermaphrodites likely indicates 
a stable array that has not integrated on a chromosome. * connotes putative integrants selected for confirmatory 
mapping by crossing with strains EG1000 and EG1020.
egl-1/Cre Plate # Total # Transgenic # Transgenic Males 
(% of Total)
# Transgenic Hermaphrodites 
(% of Total)
Interpretation
*2.3 40 23 (57.5%) 17 (42.5%) Putative Autosome Integrant
*3.8 38 20 (52.6%) 18 (47.4%) Putative Autosome Integrant
*4.16 38 14 (36.8%) 24 (63.2%) Putative Autosome Integrant
*9.7 33 12 (38.7%) 21 (63.3%) Putative Autosome Integrant
9.10 36.00 28 (77.8%) 8 (22.2%) Putative Stable Array
9.16 34 25 (73.5%) 9 (26.5%) Putative Stable Array
*10.12 30 0 (0%) 30 (100%)
Putative Sex Chromosome 
Integrant
*11.6 19 10 (52.6%) 9 (47.4%) Putative Autosome Integrant
*11.16 30 0 (0%) 30 (100%)






Mapping Strain EG1000 Mapping Strain EG1020 Interpretation
Master Plate # Dumpy (chr. I) Roll (chr. II) Long (chr. III) Blister (chr. IV) Dumpy (chr. V) Long (chr. X)
4.16 mCherry + 20 27 9 29 1 29
Integrated on 
Chr. V
mCherry - 8 5 8 1 29 12
2.3 mCherry + 17 9 12 13 16 8 Not integrated
mCherry - 17 21 19 17 15 24
9.7 mCherry + 12 20 23 5 15 6 Not integrated
mCherry - 36 17 12 29 18 24
3.8 mCherry + 17 4 26 20 22 23
Integrated on 
Chr. II
mCherry - 13 23 9 13 8 8
11.16 mCherry + 14 22 0
Integrated on 
Chr. X
mCherry - 6 9 30
10.12 mCherry + 22 24 5 29 32 11 Not integrated
mCherry - 9 7 2 2 2 22
11.6 mCherry + 16 20 14 35 1 32
Integrated on 
Chr. V
mCherry - 8 14 10 2 28 1
Table 2. Identification and mapping of egl-1/cre integrants
The table shows the correlation of visible recessive phenotypes present on the six worm chromosomes I-V and X, and 
putative integrants of an array containing mCherry. For example, among worms from an individual on master plate 
4.16, among 30 worms with the recessive ‘Dumpy’’ phenotype due to mutation on chromosome V, only one expressed 
mCherry, demonstrating anticorrelation of these traits and providing strong evidence that the extrachromosomal array 
has integrated on chromosome V. Consistent with this interpretation, no other visible marker was anticorrelated with 










*5.14 32 (52.5%) 29 (47.5%) Putative Autosome Integrant
5.18 33 (89.2%) 4 (10.8%) Putative Non-Integrant
6.12 34 (77.3%) 10 (22.7%) Putative Non-Integrant
*6.17 0 (0%) 46 (100%) Putative Sex Chromosome Integrant
*8.2 46 (61.3%) 29 (38.7%) Putative Autosome Integrant
*10.19 38 (61.3%) 24 (38.7%) Putative Autosome Integrant
Table 3. Characterization of putative cre-dependent gfp integrants crossed with N2 wts
Putative homozygous integrants (P0s) were crossed with wild-type N2 males. Transgenic male progeny of this cross (F1s) were then 
selected and crossed with wild-type N2 hermaphrodites. mCherry-positive progenies from each of the six F1 crosses were picked and 
scored for percent males and percent hermaphrodites. Results are shown in the above table. 100% of mCherry-positive progeny being 
hermaphrodites indicates a likely integration on the X chromosome. Approximately 50% transgenic progenies being male and 50% 
hermaphrodites indicates a likely integration on an autosome. Transgenic progeny that are significantly more male than 
hermaphrodites likely indicates a stable array that has not integrated on a chromosome. 





Mapping Strain EG1000 Mapping Strain EG1020 Interpretation
Master Plate # Dumpy (chr. I) Roll (chr. II) Long (chr. III) Blister (chr. IV) Dumpy (chr. V) Long (chr. X)
8.2 mCherry + 27 28 11 0 23 22
Integrated on 
Chr. IV
mCherry - 6 15 6 22 9 5
6.17 mCherry + 3 25 0
Integrated on 
Chr. X
mCherry - 0 7 23
10.19 mCherry + 6 4 7 22 23 22 Not integrated
mCherry - 24 12 24 7 8 8
5.14 mCherry + 24 0 14 20 23 19
Integrated on 
Chr. II
mCherry - 6 30 1 7 7 8
Table 4. Identification and mapping of cre-dependent gfp integrants
The table shows the correlation of visible recessive phenotypes present on the six worm chromosomes I-V and X. 
For example, among worms from an individual on master plate 8.2, among 22 worms with the recessive ‘blister’ 
phenotype due to mutation pn chromosome IV, zero expressed mCherry, demonstrating anticorrelation of these 
traits and providing strong evidence that the extrachromosomal array has integrated on chromosome IV. 
Consistent with this interpretation, no other visible marker was anticorrelated with mCherry expression in 
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